Invasive squamous carcinoma of the vulva in women aged less than 40 years: report of two cases and a third case diagnosed during pregnancy

Purpose of investigation: Invasive squamous cell cancer of the vulva (ISCC) is a rare disease in young patients and in pregnant women. The purpose of this paper was to investigate this type of cancer in women less than 40 years old and to present three cases, one which was diagnosed in the third trimester of pregnancy. Methods: Three cases of invasive squamous cell cancer in women under age 40 among the retrospectively analyzed 52 vulvar cancer cases diagnosed between 1995-2002 were investigated. Results: Women aged 25, 39 and 3 1, respectively, had Stage 1, 2 and 3 ISCC of the vulva. The first two cases had been spared by surgery and radiotherapy. The third patient was diagnosed during the last trimester of pregnancy. Although she was treated by radical surgery and postoperative radiotherapy, she had a recurrence in the inguinal region at 36 months, and died of disease 12 months later. Conclusion: Vulvar ISCC in young women may occur in association with or without predisposing factors. Although HPV-related type is predominant in the literature, keratinizing type of carcinoma may also be seen in this group of patients. Biopsy from suspected lesions is of paramount importance.

Vulva; Vulvar cancer; Pregnancy; Young

[1] Choo Y.C.: “Invasive squamous carcinoma of the vulva in young patients”. Gynecol. Oncol., 1982, 13, 158.

[2] Greenlee R.T., Hill-Harmon B.M., Murray T. et al.: “Cancer Statistics, 2001”. CA Cancer J. Clin., 2001, 51, 15, 36.

[3] Trimble C.L., Hildesheim A., Brinton L.A., Shah K.V., Kurman R.J.: “Heterogenous etiology of squamous carcinoma of the vulva”. Obstet. Gynecol., 1996, 87, 59.

[4] Monk B.J., Burger R.A., Lin F., Parham G., Vasilev S.A., Wilenzsky S.P.: “Prognostic significance of human papilloma virus DNA in vulvar carcinoma”. Obstet. Gynecol., 1995, 85, 709.

[5] Losch A., Joura E.: “Vulvar neoplasia in young women (letter to the editor)”. Gynecol. Oncol., 1999, 75, 519.

[6] Jones R.W., Baranyai J., Stables S.: “Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia”. Obstet. Gynecol., 1997, 90, 448.

[7] Carter J., Carlson J., Fowler J., Hartenbach E., Adcock I., Carson L., Twiggs L.B.: “Invasive vulvar tumors in young women - a disease of the immunosuppressed?”. Gynecol. Oncol., 1993, 51, 307.

[8] Messing M.J., Gallup D.G.: “Carcinoma of the vulva in young women”. Obstet. Gynecol., 1995, 86, 51.

[9] Carter J., Carlson J., Fowler J., Hartenbach E., Adcock L., Carson L., Twiggs L.B.: “Invasive vulvar tumors in young women - a disease of the immunosuppressed?”. Gynecol. Oncol., 1993, 51, 307.

[10] Al-Ghamdi A., Freedman D., Miller D., Poh C., Rosin M., Zhang L., Gilks C.B.: “Vulvar squamous cell carcinoma in young women: A clinicopathologic study of 21 cases”. Gynecol. Oncol., 2002, 84, 94.

[11] Jones R.W., Baranyai J., Stables S.: “Trends in squamous cell carcinoma of the vulva:the influance vulvar intraepithelial neoplasia”. Obstet. Gynecol., 1997, 90, 448.

[12] Del Priore G., Schink J.C., Lurain J.C.: “A two step approach to the treatment of invasive vulvar cancer in pregnancy”. Int. J. Gynaecol. Obstet., 1992, 39, 335.

[13] Moore D.H., Fowler W.C. Jr, Currie J.L., Walton L.A.: “Squamous cell carcinoma of the vulva in pregnancy”. Gynecol. Oncol., 1991, 41, 74.

[14] Swensen R.E., Goff B.A., Koh W.J., Petersdorf S.H., Douglas J.G., Swisher E.M., Greer B.E.: “Cancer in the pregnant patient”. In: Hoskins W.J., Young R.C., Markman M., Perez C.A., Barakat R., Randall M. “Principles and Practice of Gynecologic Oncology”, 4th edn. Philadelphia, Lippincott Williams & Wilkins, 2005, 1294.

[15] Bakour S.A., Jaleel H., Weaver J.B., Kehoe S., Radcliffe K.W.: “Vulvar carcinoma presenting during pregnancy, associated with recurrent bone marrow hypoplasia: a case report and literature review”. Gynecol. Oncol., 2002, 87, 207.

[16] Ogunleye D., Lewin S.N., Huettner P., Herzog T.J.: “Recurrent vulvar carcinoma in pregnancy”. Gynecol. Oncol., 2004, 95, 400.